АкушерствоАнатомияАнестезиологияВакцинопрофилактикаВалеологияВетеринарияГигиенаЗаболеванияИммунологияКардиологияНеврологияНефрологияОнкологияОториноларингологияОфтальмологияПаразитологияПедиатрияПервая помощьПсихиатрияПульмонологияРеанимацияРевматологияСтоматологияТерапияТоксикологияТравматологияУрологияФармакологияФармацевтикаФизиотерапияФтизиатрияХирургияЭндокринологияЭпидемиология

Лечение девочек с задержкой полового развития

Лечение при ЗПР должно быть направлено на устранение фонового заболевания, явившегося причиной отсутствия или позднего появления признаков полового созревания. Независимо от характера заболевания можно назначить замес­тительную гормональную терапию эстрогенами, а в дальнейшем терапию эстроген-гестагенными препаратами в циклическом режиме. При жела-

нии иметь детей пациентке с гонадотропным ги-погонадизмом, обусловленным поражением гипоталамо-гипофизарной системы, для индуци­рования овуляции назначают инъекции ХГ в ком­бинации с менопаузальным гонадотропином (МГ). При гипоталамическом гипогонадизме мо­жет быть назначена также пульсирующая тера­пия гонадотропином в цирхоральном режиме (Claman u. Seibel, 1990; Filicori et al, 1994; Gindoff и. Jewelewicz, 1985).

У девушек, как правило, вначале проводят за­местительную эстрогенную терапию. Ее назнача­ют с костного возраста 11—12 лет конъютирован­ными эстрогенными препаратами, начиная с дозы 0,3 мг/сут (в качестве альтернативы можно назна­чить эстрадиола валерат в дозе 0,2 мг/сут) в тече­ние 6 мес. В течение следующих 6 мес дозу конъ-югированных эстрогенов можно повысить до 0,6 мг/сут (дозу эстрадиола валерата — до 0,5 мг/сут). При проведении терапии в циклическом режиме эстрогены назначают с 1-го по 25-й день, а геста-гены — с 14-го по 25-й. Из гестагенов обычно ис­пользуют дидрогестерон (10 мг/сут), медроксип-рогестерона ацетат (2,5—5 мг/сут) или хлормади-нона ацетат (2 мг/сут). На второй год терапии дозу конъюгированных эстрогенов можно повысить до 0,9—1,25 мг/сут (эстрадиола валерата до 1—1,5 мг/сут). На третий год лечения дозу эстрогенов доводят до конечной, а именно: конъюгированных эстроге­нов до 1,25 мг/сут, эстрадиола валерата до 2 мг/сут (Stolecke, 1998). При сочетанной гипота­ламо-гипофизарной недостаточности заместитель­ную эстроген-гестагенную терапию комбинируют с назначением других гормонов: гидрокортизона, L-тироксина и гормона роста.

4.5. Заключение

Несмотря на прогресс, достигнутый в диаг­ностике и лечении преждевременного полового развития у девочек и гипогонадизма у девушек, мы еще далеки от возможности ранней диагно­стики этих состояний и восстановления нару­шенных физиологических механизмов у этих пациенток.

Препараты — антагонисты гонадолиберина за­медленного действия представляют собой класс веществ, которые благодаря отсутствию у них стимулирующего эффекта гонадолиберина, обыч­но проявляющегося в начале терапии этим гор­моном, могут заменить агонисты гонадолибери­на в лечении девочек с преждевременным поло-

вым развитием. В ближайшие годы мы надеемся оптимизировать временные особенности схемы терапии (завершение лечения агонистами гона-долиберина), а также усовершенствовать методы дифференциальной диагностики гипогонадотроп-ного гипогонадизма и конституциональной ЗПР.

Литература

Albright A. L., Lee P.A. Neurosurgical treatment of hy­pothalamic hamartomas causing precocious puberty // J. Neurosurg. - 1993. - Vol. 78. - P. 77-82.

Antoniazzi F., Cisternino M., Nizzoli G. etal. Final height in girls with central precocious puberty: comparison of two different luteinizing hormone-releasing hormone agonist treatments // Acta Paediatr. - 1994. - Vol. 83. - P. 1052— 1056.

Apter D., Biitzow T.L., Laughlin G.A., Yen S.S.C. Go-nadotropin-releasing hormone pulse generator activity dur­ing pubertal transition in girls: pulsatile and diurnal pat­terns of circulating gonadotropins // J. Clin. Endocrinol. Metab. - 1993. - Vol. 76. - P. 940-949.

Arrigo Т., Cisternino M., Galluzzi F. et al. Analysis of the factors affecting auxological response to GnRH agonist treat­ment and final height outcome in girls with idiopathic cen­tral precocious puberty // Eur. J. Endocrinol. — 1999. — Vol. 141, No. 2. - P. 140-144.

Attie KM., Ramirez N.R., Conte F.A. et al. The pubertal growth spurt in eight patients with true precocious puberty and growth hormone deficiency: evidence for a direct role of sex steroids // J. Clin. Endocrinol. Metab. — 1990. — Vol. 71. - P. 975-983.

Balagura S., Shulman K, Sobel E.H. Precocious puber­ty of cerebral origin // Surg. Neurol. — 1979. — Vol. 11. — P. 315-326.

Bay ley N., Pinneau S.R. Tables for predicting adult height from skeletal age: revised for use with the Greulich-Pyle hand standards // J. Pediatr. - 1952. - Vol. 40. - P. 423-441.

Beas F., Vargas L., Spada R.P., Merchak N. Pseudopre-cocious puberty in infants caused by a dermal ointment containing estrogens // Ibid. — 1969. — Vol. 75. — P. 127— 130.

Beck W., Wuttke W. Diurnal variations of plasma lutein­izing hormone, follicle-stimulating hormone, and prolac­tin in boys and girls from birth to puberty // J. Clin. Endo­crinol. Metab. - 1980. - Vol. 50. - P. 635-639.

Benedict P. Endocrine features in Albright's syndrome (fibrous dysplasia of bone) // Metabolism. — 1962. — Vol. 11. - P. 30-45.

Bernaschek G, Lubec G, Schaller A. Sonographische Untersuchungen uber das Wachstum von Uterus und Ova-

rien zwischen dem 1.-14. Lebensjahr//Geburtshilfe Frauen-heilkd. - 1984. - Bd 44. - S. 727-730.

Bertelloni S., Baroncelli G.I., Sorrentino M.C. et al. Ef­fect of central precocious puberty and gonadotropin-re-leasing hormone analogue treatment on peak bone mass and final height in females // Eur. J. Pediatr. — 1998. — Vol. 157, No. 5. - P. 363-367.

Betterle C, Rossi A., Dalla Pria S. et al. Premature ova­rian failure: autoimmunity and natural history // Clin. Endocrinol. (Oxf). - 1993. - Vol. 39, No. 1. - P. 35-43.

Bhettay E., Bonnici F. Pure oestrogen-secreting feminiz­ing adrenocortical adenoma // Arch. Dis. Child. — 1977. — Vol. 52. - P. 241-243.

Bourguignon J.-P., Gerard A., Alvarez Gonzalez M.L. et al. Effects of changes in nutritional conditions on timing of puberty: clinical evidence from adopted children and exper­imental studies in the male rat // Horm. Res. — 1992a. — Vol. 38. - Suppl. 1. - P. 97-105.

Bourguignon J.-P., Gerard A., Alvarez Gonzalez. M.L., Franchimont P. Neuroendocrine mechanism of onset of puberty. Sequential reduction in activity of inhibitory and facilitatory N-methyl-D-aspartate receptors // J. Clin. In­vest. - 1992b. - Vol. 90. - P. 1736-1744.

Boyar R.M., Finkelstein J. W., David R. et al. Twenty-four hour pattern of plasma luteinizing hormone and folli­cle-stimulating hormone in sexual precocity // N. Engl. J. Med. - 1974. - Vol. 289. - P. 282-286.

Brann D. W., Mahesh V.B. Excitatory amino acids: func­tion and significance in reproduction and neuroendocrine regulation // Front. Neuroendocrinol. — 1994. — Vol. 15, No. 1. - 3-49.

Bundscherer F., Deeg K.H. Die sonographische Beurtei-lung der Uterasentwicklung im Kindesalter // Monatsschr. Kinderheilkd. - 1988. - Bd 136. - S. 246-250.

Carel J.C., Roger M., Ispas S. et al. Final height after long-term treatment with triptorelin slow release for cen­tral precocious puberty: importance of statural growth af­ter interruption of treatment. French study group of De-capeptyl in Precocious Puberty // J. Clin. Endocrinol. Metab. - 1999. - Vol. 84, No. 6. - P. 1973-1978.

Chaussain J.L., Swaenepoel C, Bost M. et al. Growth and ovarian function in girls with central precocious puberty after interruption of LHRH agonist therapy // Sexual Precocity. Etiology, Diagnosis, and Management / Eds G.D. Grave, G.B. Cutler Jr. - N.Y.: Raven Press, 1993. - P. 55-59.

Cisternino M., Arrigo Т., Pasquino A.M. et al. Etiology and age incidence of precocious puberty in girls: a multi­centric study // J. Pediatr. Endocrinol. Metab. — 2000. — Vol. 13. - Suppl. 1. - P. 695-701.

Cisternino M., Pasquino A.M., Bozzola M. et al. Final height attainment and gonadal function in girls with pre­cocious puberty treated with cyproterone acetate // Horm. Res. - 1992. - Vol. 37. - P. 86-90.

Claman P., Seibel ММ. Ovulation induction: GnRH // Infertility / Ed. M.M. Seibel. — Norwalk: Appleton and Lange, 1990. - P. 333-350.

Comite F., Schiebinger R.J., Albertson B.D. et al. Isosex-ual precocious pseudopuberty secondary to a feminizing adrenal tumor // J. Clin. Endocrinol. Metab. — 1984. — Vol. 58. - P. 435-440.

Conte F.A., Grumbach MM., Kaplan S.L. A diphasic pattern of gonadotropin secretion in patients with the syn­drome of gonadal dysgenesis // Ibid. — 1975. — Vol. 40. — P. 670-674.

Conte F.A., Grumbach MM., Kaplan S.L., Reiter E.O. Correlation of luteinizing hormone-releasing factor-induced luteinizing hormone and follicle-stimulating hormone release from infancy to 19 years with the changing pattern of gona­dotropin secretion in agonadal patients: relation to the re­straint of puberty // Ibid. - 1980. - Vol. 50. - P. 163-168.

Cronen P. W., Nagaraj H.S. Ovarian tumors in children // South. Med. J. - 1988. - Vol. 81. - P. 464-468.

Cronje H.S., Niemand I., Bam R.H., Woodruff J. D. Gran­ulosa and theca cell tumors in children: a report of 17 cases and literature review // Obstet. Gynecol. Surv. — 1998. - Vol. 53, No. 4. - P. 240-247.

Dewhurst C.J. Precocious sexual development of ovarian origin // The Gynecology of Childhood and Adolescence // Eds J.W. Huffman, C.J. Dewhurst, V.J. Capraro. — Philadel­phia: Saunders, 1981. - P. 362-367.

Distler W., Kuhrke H., Jurgens H., Graf M. Puberty and ovarian function following cytostatic therapy in childhood // Geburtshilfe Frauenheilkd. - 1986. - Bd 46. - S. 237-241.

Doring G.K. Uber die relative Sterilitat in den Jahren nach der Menarche // Ibid. - 1963. - Bd 23. - S. 30-36.

Dorr H.G., Sippell W.G., Drop S.L.S. et al. Evidence of 11 -beta-hydroxylase deficiency in childhood adrenocortical tumors. The plasma corticosterone/11 -deoxycorticosterone ratio as a possible marker for malignancy // Cancer. — 1987. — Vol. 60. - P. 1625-1629.

Drop S.L.S., Braining G.J., Visser H.K.A., Sippell W.G. Prolonged galactorrhoea in a 6-year-old girl with isosexual precocious puberty due to a feminizing adrenal tumour // Clin. Endocrinol. (Oxf). - 1981. - Vol. 15. - P. 3743.

Ehren I.M., Mahour G.H., Isaacs H. Jr. Benign and malignant ovarian tumors in children and adolescents. A review of 63 cases // Am. J. Surg. - 1984. - Vol. 147. - P. 339-344.

Feuillan P.P., Foster СМ., Pescovitz O.H. et al. Treat­ment of precocious puberty in the McCune-Albright syn­drome with the aromatase inhibitor testolactone // N. Engl. J. Med. - 1986. - Vol. 315. - P. 1115-1119.

Feuillan P.P., Jones J., Cutler G.B. Jr. Long term testolac­tone therapy for precocious puberty in girls with the Mc­Cune-Albright syndrome // J. Clin. Endocrinol. Metab. — 1993. - Vol. 77. - P. 647-651.

Filicori M., Flamigni C, Dellai P. et al. Treatment of ano­vulation with pulsatile gonadotropin-releasing hormone: prog­nostic factors and clinical results in 600 cycles // Ibid. —

1994. - Vol. 79. - P. 1215-1220.

Forest M.G Pituitary gonadotropin and sex steroid secre­tion during the first two years of life // Control of the Onset of Puberty / Eds M.M. Grumbach, P.C. Sizonenko, M.L. Aub-ert. - Baltimore: Williams and Wilkins, 1990. - P. 451-478.

Foster СМ., Ross J.L., Shawker T. et al. Absence of pubertal gonadotropin secretion in girls with McCune-Al-bright syndrome // J. Clin. Endocrinol. Metab. — 1984. — Vol. 58. - P. 1161-1165.

Gay V.L., Plant TM. N-Methyl-D,L-aspartate elicits hypothalamic gonadotropin-releasing hormone release in prepubertal male rhesus monkeys (Macaca mulatta) // Endocrinology. - 1987. - Vol. 120. - P. 2289-2296.

Gindoff P.R., Jewelewicz R. Use of gonadotropin in ovu­lation induction // N.Y. State J. Med. - 1985. - Vol. 85. -P. 580-584.

Girard J., Baumann J.В., Buhler U. et al. Cyproterone acetate and ACTH adrenal function // J. Clin. Endocrinol. Metab. - 1978. - Vol. 41. - P. 581-586.

Gluckman P.D., Marti-Henneberg C, Kaplan S.L., Grum­bach M.M. Hormone ontogeny in the ovine fetus: XIV. The effects of 17p-estradiol infusion on fetal plasma gona­dotropins and prolactin and the maturation of sex steroid-dependent negative feedback // Endocrinology. — 1983. — Vol. 112. - P. 1618-1623.

Greulich W. W., Pyle S.L Radiographic atlas of skeletal development of the hand and wrist. — 2nd ed. — Stanford: Stanford University Press, 1959.

Griffin L.J., Cole T.J., Duncan K.A. et al. Pelvic ultra­sound measurements in normal girls // Acta Paediatr. —

1995. - Vol. 84. - P. 536-543.

Grumbach M.M. True or central precocious puberty // Current Therapy in Endocrinology and Metabolism / Eds D.R. Krieger, C.W. Bardin. - St Louis: B.C. Decker; C.V. Mosby, 1985. - P. 4-8.

Grumbach MM., Kaplan S.L. Recent advances in the diagnosis and management of sexual precocity // Acta Pae­diatr. Jpn. - 1988. - Vol. 30. - Suppl. - P. 155-175.

Grumbach MM., Kaplan S.L. The neuroendocrinology of human puberty: an ontogenetic perspective // Control of the Onset of Puberty / Eds M.M. Grumbach, P.C. Si­zonenko, M.L. Aubert. — Baltimore: Williams and Wilkins, 1990. - P. 1-68.

Grumbach MM., Styne DM. Puberty: ontogeny, neu­roendocrinology, physiology, and disorders // Williams Textbook of Endocrinology /Eds J.D. Wilson, D.W. Fos­ter, H.M. Kronenberg, P.R. Larsen. — Philadelphia; Lond.; Toronto: W.B. Saunders, 1998. - P. 1509-1625.

Harris D.A., Van Vliet G., Egli C.A. et al. Somatome-din-C in normal puberty and in true precocious puberty

before and after treatment with a potent luteinizing hor­mone-releasing hormone agonist // J. Clin. Endocrinol. Metab. - 1985. - Vol. 61. - P. 152-159.

Hauffa B.P. Klinische und laboranalytische Messwerte // Endokrinologie des Kindes- und Jugendalters. 3. Aufl. / Stolecke H. (Hrsg). — Berlin; Heidelberg; N.Y.: Springer, 1997. - S. 549-603.

Hauffa B.P. Pubertas tarda // Der jugendliche Patient / Dorr H.G., Rascher W. (Hrsg). — Munchen: Urban and Fischer, 2001.

Hauffa B.P., Havers W., Stolecke H. Short-term effects of testolactone compared to other treatment modalities on longitudinal growth and ovarian activity in a girl with Mc-Cune-Albright syndrome // Helv. Paediatr. Acta. — 1987. — Vol. 42. - P. 471-480.

Hazum E., Conn P.M. Molecular mechanism of gona-dotropin-releasing hormone (GnRH) action. I. The GnRH receptor // Endocr. Rev. - 1988. - Vol. 9. - P. 379-386.

Heger S., Partsch C.J., Sippell W.G. Long-term outcome after deport gonadotropin-releasing hormone agonist treat­ment of central precocious puberty: final height, body pro­portions, body composition, bone mineral density, and re­productive function // J. Clin. Endocrinol. Metab. — 1999. — Vol. 84, No. 12. - P. 4583-4590.

Heinze F., Teller W.M., Fehm H.L., Joos A. The effect of cyproterone acetate on adrenal cortical function in chil­dren with precocious puberty // Eur. J. Pediatr. — 1978. — Vol. 128. - P. 81-88.

Helge H. Fruhreife // Monatsschr. Kinderheilkd. — 1973. - Vol. 121. - P. 636-646.

Hertz R- Accidental ingestion of estrogens by children // Pediatrics. - 1958. - Vol. 21. - P. 203-206.

Huckle W.R., Conn P.M. Molecular mechanism of go­nadotropin-releasing hormone action. II. The effector sys­tem // Endocr. Rev. - 1988. - Vol. 9. - P. 387-395.

Jung H., Carmel P., Schwartz M.S. et al. Some hypo­thalamic hamartomas contain transforming growth factor a, a puberty-inducing growth factor, but not luteinizing hormone-releasing hormone neurons//J. Clin. Endocrinol. Metab. - 1999. - Vol. 84, No. 12. - P. 4695-4701.

Kaplan S.L., Grumbach M.M. Pituitary and placental gonadotropins and sex steroids in the human and sub-hu­man primate fetus // Clin. Endocrinol. Metab. — 1978. — Vol. 7. - P. 487-511.

Kaplan S.L., Grumbach M.M. Clinical review 14: Patho­physiology and treatment of sexual precocity // J. Clin. Endocrinol. Metab. - 1990. - Vol. 71. - P. 785-789.

Kato K., Fujimoto M., Hibi I. et al. The long-term effect of cyproterone acetate on growth in girls with idiopathic precocious puberty. Androcur Study Group in Japan // Eur. J. Pediatr. - 1993. - Vol. 152, No. 4. - P. 297-300.

Kaufman F.R., Xu Y.K., Ng W.G., Donnell G.N. Corre­lation of ovarian function with galactose-1-phosphate uridyl

transferase levels in galactosemia // J. Pediatr. — 1988. — Vol. 112. - P. 754-756.

Kauli R., Galatzer A., Kornreich L. et al. Final height of girls with central precocious puberty, untreated versus treated with cyproterone acetate or GnRH analogue — a comparative study with re-evaluation of predictions by the Bayley-Pinneau meth­od // Horm. Res. - 1997. - Vol. 47, No. 2. - P. 54-61.

Kelch R.P. Management of precocious puberty // N. Engl. J. Med. - 1985. - Vol. 312. - P. 1057-1058.

Kletter G.B., Kelch R.P. Clinical review 60: Effects of go­nadotropin-releasing hormone analog therapy on adult stat­ure in precocious puberty // J. Clin. Endocrinol. Metab. — 1994. -Vol. 79. - P. 331-334.

Kulin H.E., Grumbach M.M., Kaplan S.L. Changing sensitivity of the pubertal gonadal hypothalamic feedback mechanism in man // Science. — 1969. — Vol. 166. — P. 1012-1013.

Kulin H.E., Grumbach M.M., Kaplan S.L. Gonadal-hypo­thalamic interaction in prepubertal and pubertal man: effect of clomiphene citrate on urinary follicle-stimulating hormone and luteinizing hormone and plasma testosterone // Pediatr. Res. - 1972. - Vol. 6. - P. 162-171.

Largo R.H., Prader A. Pubertal development in Swiss girls // Helv. Paediatr. Acta. - 1983. - Vol. 38. - P. 229-243.

Luna A.M., Wilson D.M., Wibbelsman C.W. et al. So­matomedins in adolescence: a cross-sectional study of the effect of puberty on plasma insulin-like growth factor I and II levels // J. Clin. Endocrinol. Metab. - 1983. - Vol. 57. -P. 268-271.

Lyon A.J., De-Bruyn R., Grant D.B. Transient sexual precocity and ovarian cysts // Arch. Dis. Child. — 1985. — Vol. 60. - P. 819-822.

Ma Y.J., Hill D.F., Creswick K.E. et al. Neuregulins sig­naling via a glial erbB-2-erbB-4 receptor complex contrib­ute to the neuroendocrine control of mammalian sexual development // J. Neurosci. - 1999. - Vol. 19, No. 22. -9913-9927.

Mahachoklertwattana P., Kaplan S.L., Grumbach M.M. The luteinizing hormone-releasing hormone-secreting hy­pothalamic hamartoma is a congenital malformation: nat­ural history // J. Clin. Endocrinol. Metab. - 1993. - Vol. 77. - P. 118-124.

Marshall W.A., Tanner J.M. Puberty// Human Growth / Eds F. Falkner, J.M. Tanner. - N.Y.: Plenum. 1986. -P. 171-209.

Michael R.P., Zumpke D. Behavioural changes associ­ated with puberty in higher primates and the human // Control of the Onset of Puberty / Eds M.M. Grumbach, P.C. Sizonenko, M.L. Aubert. — Baltimore: Williams and Wilkins. 1990. - P. 574-587.

Money J., Clopper R.R. Jr. Psychosocial and psychosex-ual aspects of errors of pubertal onset and development // Hum. Biol. - 1974. - Vol. 46. - P. 173-181.

Mouridsen S.E., Larsen F.W. Psychological aspects of precocious puberty. An overview // Acta Paedopsychiatr. — 1992. - Vol. 55. - P. 45-49.

Murrain D., Dewhurst J., Grant D.B. Premature me-narche: a follow-up study // Arch. Dis. Child. — 1983. — Vol. 58. - P. 142-143.

Noonan J.A. Hypertelorism with Turner phenotype. A new syndrome with associated congenital heart disease // Am. J. Dis. Child. - 1968. - Vol. 116. - P. 373-380.

Oerter K.E., Manasco P., Barnes KM. et al. Adult height in precocious puberty after long-term treatment with deslorelin // J. Clin. Endocrinol. Metab. - 1991. - Vol. 73. - P. 1235-1240.

Ogilvy'Stuart A.L., Clark D.J., Wallace W.H.B. et al. Endocrine deficit after fractionated total body irradiation // Arch. Dis. Child. - 1992. - Vol. 67. - P. 1107-1110.

Ohlsson C, Isgaard J., Tornell J. et al. Endocrine regula­tion of longitudinal bone growth // Acta Paediatr. — 1993. — Vol. 82. - Suppl. 391. - P. 33-40.

Oostdijk W., Rikken В., Schreuder S. et al. Final height in central precocious puberty after long term treatment with a slow release GnRH agonist // Arch. Dis. Child. — 1996. - Vol. 75, No. 4. - P. 292-297.

Orsini L.F., Salardi S., Pilu G. et al. Pelvic organs in premenarcheal girls: real-time ultrasonography // Radiol­ogy. - 1984. - Vol. 153. - P. 113-116.

Parker L.N. Adrenarche // Endocrinol. Metabol. Clin. North Am. - 1991. - Vol. 20. - P. 71-83.

Partsch C.J., Hummelink R., Lorenzen F., Sippell W.G Bedeutung und Charakteristika des LHRH-Testes in der Diagnostik der vorzeitigen Pubertatsentwicklung bei Mad-chen: Der stimulierte LH-FSH-Quotient differenziert zwis-chen zentraler Pubertas praecox und pramaturer Thelarche. Die deutsche Decapeptyl-Depot-Studiengrappe // Monatss-chr. Kinderheilkd. - 1989. - Bd 137. - S. 284-288.

Partsch C.J., Hummelink R., Sippell W.G. Reference ranges of lutropin and follitropin in the luliberin test in prepubertal and pubertal children using a monoclonal immunoradio-metric assay // J. Clin. Chem. Clin. Biochem. — 1990. — Vol. 28. - P. 49-52.

Paul D., Conte F.A., Grumbach M.M., Kaplan S.L. Dong term effect of gonadotropin-releasing hormone agonist therapy on final and near-final height in 26 children with true preco­cious puberty treated at a median age of less than 5 years // J. Clin. Endocrinol. Metab. - 1995. - Vol. 80. - P. 546-551.

Perheentupa J., Miettinen A. Type 1 autoimmune polyglan­dular disease // Ann. Med. Interne (Paris). — 1999. — Vol. 150, No. 4. - P. 313-325.

Pescovitz O.H., Flench K.D., Barnes KM. et al. Prema­ture thelarche and central precocious puberty: the relation­ship between clinical presentation and the gonadotropin re­sponse to luteinizing hormone-releasing hormone // J. Clin. Endocrinol. Metab. - 1988. - Vol. 67. - P. 474-479.

Prader A. Pubertatsentwicklung: Was ist normal? Was 1st auffallend oder pathologisch? Einige grundsatzliche Be-trachtungen // Helv. Paediatr. Acta. - 1983. - Vol. 38. -P. 197-202.

Prader A. Growth and development // Clinical Endo­crinology. Theory and Practice / Ed. A. Labhart. — Berlin; Heidelberg; N.Y.: Springer, 1986a. - P. 1013-1059.

Prader A. Physiologisches, pathologisches und manipuli-ertes Korperwachstum // Monatsschr. Kinderheilkd. — 1986b. - Vol. 134. - P. 292-301.

Proos L.A. Anthropometry in adolescence — secular trends, adoption, ethnic and environmental differences // Horm. Res. - 1993. - Vol. 39. - Suppl. 3. - P. 18-24.

Ranke M.B., Chavez- Meyer H., Blank B. et al. Sponta­neous growth and bone age development in Turner syn­drome: results of a multicentric study 1990 // Turner Syn­drome: Growth Promoting Therapies / Eds MB. Ranke, R.G. Rosenfeld. — Amsterdam: Elsevier Science Publish­ers, 1990. - P. 101-106.

Regis J., Bartolomei F., De Foffol B. et al. Gamma knife surgery for epilepsy related to hypothalamic hamartomas // Neurosurgery. - 2000. - Vol. 47, No. 6. - P. 1343-1351.

Rieth KG, Comite F, Shawker F.H., Cutler G.B. Jr. Pituitary and ovarian abnormalities demonstrated by CT and ultrasound in children with features of the McCune-Albright syndrome // Radiology. - 1984. - Vol. 153. - P. 389-393.

Riley W.J. Autoimmune polyglandular syndromes // Horm. Res. - 1992. - Vol. 38. - Suppl. 2. - P. 9-15.

Roche A.F. The final phase of growth in stature // Growth, Genetics and Hormones. — 1989. — Vol. 5. — P. 4—6.

Rosenfeld J. V., Harvey A.S., Wrennall J. et al. Transcal­losal resection of hypothalamic hamartomas, with control of seizures, in children with gelastic epilepsy // Neurosur­gery. - 2001. - Vol. 48, No. 1. - P. 108-118.

Rosenfleld R.L, Furlanetto R., Bock D. Relationship of somatomedin-C concentrations to pubertal changes // J. Pediatr. - 1983. - Vol. 103. - P. 723-728.

Roth H., Daum R., Benz G., Schqfer K. Rare ovarian tumors in childhood // Eur. J. Pediatr. Surg. — 1991. — Vol. 1. - P. 210-215.

Saenz de Rodriguez C.A., Bongiovanni A.M., Conde de Borrego L. An epidemic of precocious development in Pu­erto Rican children // J. Pediatr. - 1985. - Vol. 107. - P. 393-396.

Saggese G, Bertelloni S., Baroncelli G.I. et al. Reduction of bone density: an effect of gonadotropin-releasing hormone analogue treatment in central precocious puberty // Eur. J. Pediatr. - 1993. - Vol. 152. - P. 717-720.

Salardi S., Orsini L.F., Cacciari E. et al. Pelvic ultra­sonography in premenarcheal girls: relation to puberty and sex hormone concentrations // Arch. Dis. Child. — 1985. — Vol. 60. - P. 120-125.

Salardi S., Orsini L.F., Cacciari E. et al. Pelvic ultra­sonography in girls with precocious puberty, congenital adrenal hyperplasia, obesity, or hirsutism // J. Pediatr. — 1988. - Vol. 112. - P. 880-887.

Schoevaart C.E., Drop S.L., Often B.J. et al. Growth analysis up to final height and psychosocial adjustment of treated and untreated patients with precocious puberty // Horm. Res. - 1990. - Vol. 34. - P. 197-203.

Schwanzel-Fukuda M., Jorgenson K.L., Bergen H.T. et al. Biology of normal luteinizing hormone-releasing hor­mone neurons during and after their migration from olfac­tory placode // Endocr. Rev. - 1992. - Vol. 13. - P. 623-634.

Shalet S.M., Crowne E.C., Didi M.A. et al. Irradiation-induced growth failure // Baillieres Clin. Endocrinol. Metab. - 1992. - Vol. 6. - P. 513-526.

Sharland M., Burch M., McKenna W.M., Paton M.A. A clinical study of Noonan syndrome // Arch. Dis. Child. — 1992. - Vol. 67. - P. 178-183.

Shawker Т.Н., Comite F., Rieth KG et al. Ultrasound evaluation of female isosexual precocious puberty // J. Ultrasound Med. - 1984. - Vol. 3, No. 7. - P. 309-316.

Sklar C.A., Conte F.A., Kaplan S.L., Grumbach M.M. Human chorionic gonadotropin-secreting pineal tumor: relation to pathogenesis and sex limitation of sexual pre­cocity // J. Clin. Endocrinol. Metab. - 1981. - Vol. 53. -P. 656-660.

Sonis W.A., Comite F., Blue J. et al. Behaviour prob­lems and social competence in girls with true precocious puberty // J. Pediatr. - 1985. - Vol. 106. - P. 156-160.

Sorgo W., Kiraly E., Haupenthal M. et al. Precocious puberty (PP): effects on growth in patients treated with cyproterone acetate (CYP) // Acta Endocrinol. (Copenh.) Suppl. - 1993. -Vol. 111. - P. 1.

Stivel M.S., Kauli R., Kaufman H., Laron Z. Adreno­cortical function in children with precocious sexual devel­opment during treatment with cyproterone acetate // Clin. Endocrinol. (Oxf). - 1982. - Vol. 16. - P. 163-169.

Stolecke H. Storungen der Pubertatsentwicklung // En-dokrinologie des Kindes- und Jugendalters. 3. Aufl. / Stolecke H. (Hrsg). - Berlin; Heidelberg; N.Y.: Springer, 1997. - S. 378-398.

Stolecke H. Sexualsteroide bei Ullrich-Turner-Syndrom und Panhypopituitarismus. 2. Aufl. — Ankum-Kettenka-mp: Verlag Dokument u Bild, 1998.

Styne D.M., Harris D.A, Egli C.A. et al. Treatment of true precocious puberty with a potent luteinizing hormone-releasing factor agonist: effect on growth, sexual matura­tion, pelvic sonography, and the hypothalamic-pituitary-gonadal axis // J. Clin. Endocrinol. Metab. — 1985. — Vol. 61. - P. 142-151.

Tanaka Т., Hibi L, Kato К et al. Two-year results of sustained-release leuprorelin acetate (TAP-144-SR) treat­ment in children with central precocious puberty // Clin. Pediatr. Endocrinol. - 1993. - Vol. 2. - P. 49-58.

Tanner J.M. Growth at adolescence. — 2nd ed. — Ox­ford; Edinburgh: Blackwell Scientific Publications, 1962.

Tanner J.M., Eveleth P.B. Variability between populations in growth and development at puberty // Puberty, biologic and psychosocial components / Ed. S.R. Berenberg. — Leiden: Kluwer Academic Publishers, 1975. - P. 256-273.

Tanner J.M., Whithouse R.H., Marshall W.A. et al. As­sessment of skeletal maturity and prediction of adult height (TW 2 method). - N.Y.: Academic Press, 1975.

Tuvemo Т., Gustafsson J., Proos L.A. Growth hormone treatment during suppression of early puberty in adopted girls. Swedish Growth Hormone Advisory Group // Acta Paediatr. - 1999. - Vol. 88, No. 9. - P. 928-932.

Van Wieringen J.C. Secular Growth Changes // Hu­man Growth / Eds F. Falkner, M. Tanner. — NY.: Ple­num Publishers, 1986. - P. 307-331.

Van Wieringen J.C, Wafelbakker F., Verbrugge H.P., de Haas J.H. Growth Diagrams 1965 Netherlands: Second National Survey on 0—24 year olds. — Groningen: Wolters-Noordhoff Publishing, 1971.

Van Wyk J.J., Grumbach M.M. Syndrome of preco­cious menstruation and galactorrhea in juvenile hypothy­roidism: an example of hormonal overlap in pituitary feed­back // J. Pediatr. - 1960. - Vol. 57. - P. 416-435.

Virdis R., Street M.E., Zampolli M. et al. Precocious puberty in girls adopted from developing countries // Arch. Dis. Child. - 1998. - Vol. 78, No. 2. - P. 152-154.

Weinstein L.S., Shenker A., Gejman P. V. et al. Activat­ing mutations of the stimulatory G protein in the Mc-Cune-Albright syndrome (see comments) // N. Engl. J. Med. - 1991. - Vol. 325. - P. 1688-1695.

Winter J.S.D., Faiman C, Hobson W.C et al. Pituitary-gonadal relations in infancy: I. Patterns of serum gonadot­ropin concentrations from birth to four years of age in man and chimpanzee // J. Clin. Endocrinol. Metab. — 1975. — Vol. 40. - P. 545-551.

Winter J.S.D., Hughes LA., Reyes F.I., Faiman С Pitu-itary-gonadal relations in infancy. II. Patterns of serum gonadal steroid concentrations in man from birth to two years of age // Ibid. - 1976. - Vol. 42. - P. 679.

Yanovski J.A., Nelson LM., Willis E.D., Cutler G.B. Jr. Repeated, childhood vaginal bleeding is not always preco­cious puberty// Pediatrics. - 1992. - Vol. 89. - P. 149-151.

Zaatreh M., Tennison M., Greenwood R.S. Successful treatment of hypothalamic seizures and precocious puber­ty with GnRH analogue // Neurology. - 2000. - Vol. 55, No. 12. - P. 1908-1910.

Дата добавления: 2014-12-11 | Просмотры: 1878 | Нарушение авторских прав